Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1233
https://www.valueinhealthjournal.com/article/S1098-3015(16)32599-2/fulltext
Title :
Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32599-2&doi=10.1016/j.jval.2016.09.1233
First page :
A559
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1156